Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy

BACKGROUND: Despite recent advances in cancer immunotherapy, the efficacy of these therapies for the treatment of human prostate cancer patients is low due to the complex immune evasion mechanisms (IEMs) of prostate cancer and the lack of predictive biomarkers for patient responses. METHODS: To unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Bou-Dargham, Mayassa J., Sha, Linlin, Sang, Qing-Xiang Amy, Zhang, Jinfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302357/
https://www.ncbi.nlm.nih.gov/pubmed/32552802
http://dx.doi.org/10.1186/s12885-020-07058-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302357/
https://www.ncbi.nlm.nih.gov/pubmed/32552802
http://dx.doi.org/10.1186/s12885-020-07058-y

Ejemplares similares